TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01660347 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT00824993 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03389477 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT03389477 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study NCT03242707 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT02678182 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00435513 — Predictive Biomarker (PRD); Safety Biomarker (SAF): SRD5A2 mRNA
Genes: SRD5A2
Study NCT01348308 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study NCT01348308 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02758509 — Predictive Biomarker (PRD): BOC mRNA
Genes: BOC; UNQ604/PRO1190
Study NCT01850901 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02021019 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04510688 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04510688 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00703053 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00004875 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT04507646 — Pharmacodynamic Biomarker (PDY): Salivary secretion
Study NCT03228069 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04170790 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04759261 — Predictive Biomarker (PRD): SMAD4 mRNA
Genes: SMAD4; DPC4; MADH4
Study NCT00219024 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03324230 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT03324230 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01950949 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01565668 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01168908 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT03928548 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00095355 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT00095355 — Safety Biomarker (SAF): BDNF
Study NCT02954939 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03062878 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00300066 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT03531320 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT02696421 — Predictive Biomarker (PRD): TEF mRNA
Genes: TEF; KIAA1655
Study NCT02901925 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00394836 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05762523 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01870557 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01204606 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03771586 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT00907595 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02012296 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT04616196 — Predictive Biomarker (PRD): NKTR mRNA
Genes: NKTR
Study NCT03641417 — Predictive Biomarker (PRD): MBOAT4 mRNA
Genes: MBOAT4; GOAT; OACT4; FKSG89
Study NCT01904201 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01904201 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01810835 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00846651 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03625635 — Safety Biomarker (SAF): Interleukin 1 alpha
Genes: IL1A; IL1F1
Study NCT03625635 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 1 beta
Genes: IL1B; IL1F2
Study NCT03625635 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03625635 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT03625635 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT03625635 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT03625635 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT03625635 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT03625635 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03625635 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT01237717 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06393621 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01245010 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04030039 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04030039 — Monitoring Biomarker (MOI): HBV DNA
Study NCT00647153 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02677337 — Predictive Biomarker (PRD): DCN mRNA
Genes: DCN; SLRR1B
Study NCT04183153 — Predictive Biomarker (PRD): TRH mRNA
Genes: TRH
Study NCT04183153 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT03890991 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04442191 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04391374 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT04391374 — Predictive Biomarker (PRD): Coagulation factor VIII
Genes: F8; F8C
Study NCT01000090 — Predictive Biomarker (PRD): SMS mRNA
Genes: SMS
Study NCT04137926 — Pharmacodynamic Biomarker (PDY): Amyloid beta peptide (1-40)
Genes: APP; A4; AD1
Study NCT04137926 — Predictive Biomarker (PRD): PSEN1 mRNA
Genes: PSEN1; AD3; PS1; PSNL1
Study NCT04375579 — Predictive Biomarker (PRD): CGA mRNA
Genes: CGA
Study NCT03842163 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01207102 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01207102 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00139152 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04355754 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01914003 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study NCT00741325 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00741325 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT03509636 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT00727233 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT00202280 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT02979977 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02152891 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01191541 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03267953 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03934255 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00323908 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT03861689 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03861689 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT00052039 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT00334945 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01364623 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT04311606 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03084666 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT03084666 — Safety Biomarker (SAF): Interleukin 18
Genes: IL18; IGIF; IL1F4
Study NCT03974334 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02091583 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00706550 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02807051 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00645099 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00645099 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03881384 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03219476 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03219476 — Predictive Biomarker (PRD): Hormone receptor
Study NCT01134835 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT04284774 — Predictive Biomarker (PRD): HRAS mRNA
Genes: HRAS; HRAS1
Study NCT03549299 — Predictive Biomarker (PRD): ABCB5 mRNA
Genes: ABCB5
Study NCT01365585 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00040781 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00579683 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00579683 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00579683 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT00579683 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT00579683 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00579683 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04406363 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02770443 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04221854 — Predictive Biomarker (PRD): SDC2 mRNA
Genes: SDC2; HSPG1
Study NCT03217942 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00307333 — Predictive Biomarker (PRD): HRC mRNA
Genes: HRC; HCP
Study NCT04609332 — Predictive Biomarker (PRD): ANG mRNA
Genes: ANG; RNASE5
Study NCT04609332 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04458272 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT04458272 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT00250666 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT01909323 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT01425515 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00061568 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT03615235 — Predictive Biomarker (PRD): APOL1 mRNA
Genes: APOL1; APOL
Study NCT01105091 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00633464 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00633464 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00633464 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01758458 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01484899 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT06650345 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06650345 — Safety Biomarker (SAF): Cytochrome c
Study NCT01965977 — Predictive Biomarker (PRD): EFS mRNA
Genes: EFS; CASS3
Study NCT03216811 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03580889 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00696410 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00696410 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05116150 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01148849 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02370589 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03134846 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03134846 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04353167 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04054089 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04750824 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT04216953 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00717808 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02678143 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT04416061 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03662217 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT04064879 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT04292249 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02038530 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04180150 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03332329 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT03332329 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02659761 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04144569 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02057224 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00121836 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00741026 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00097487 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04472143 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04472143 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04472143 — Predictive Biomarker (PRD): ERBB4 mRNA
Genes: ERBB4; HER4
Study NCT04472143 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03145064 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05814224 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00452049 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03340649 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03775863 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00837434 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00837434 — Predictive Biomarker (PRD): CD27 mRNA
Genes: CD27; TNFRSF7
Study NCT00171444 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00930722 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02963038 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02801955 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT02248259 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT03486886 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01570439 — Predictive Biomarker (PRD): KIF20A mRNA
Genes: KIF20A; MKLP2; RAB6KIFL
Study NCT01489943 — Predictive Biomarker (PRD); Safety Biomarker (SAF): ABCG2
Genes: EST157481; MXR; BCRP; ABCP; CD338
Study NCT01489943 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT03977558 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02237781 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT00890253 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT04169022 — Predictive Biomarker (PRD): IL1RAP mRNA
Genes: IL1RAP; C3orf13; IL1R3
Study NCT04169022 — Safety Biomarker (SAF): Interleukin 1
Study NCT03939624 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03939624 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT02842203 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03799094 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03799094 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04878835 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04878835 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04878835 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03132428 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04197934 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04807699 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04195945 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02338011 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02101775 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT00992628 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02616757 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01468220 — Predictive Biomarker (PRD): Hypoxia-inducible factor 1-alpha
Genes: HIF1A; BHLHE78; MOP1; PASD8
Study NCT02365649 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03904394 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03443505 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00740532 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00740532 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT00740532 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT00740532 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT00740532 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00740532 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04541290 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03975270 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT00515255 — Predictive Biomarker (PRD): NPL mRNA
Genes: NPL; C1orf13
Study NCT01138267 — Predictive Biomarker (PRD): Multidrug resistance protein 1
Genes: ABCB1; MDR1; PGY1
Study NCT00099996 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00998049 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00998049 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02018406 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00064220 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT00709111 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02267603 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT00491322 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT01956734 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT05378646 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01157520 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00929604 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02224599 — Predictive Biomarker (PRD): PTTG1 mRNA
Genes: PTTG1; EAP1; PTTG; TUTR1
Study NCT01553175 — Predictive Biomarker (PRD): SMARCA2 mRNA
Genes: SMARCA2; BAF190B; BRM; SNF2A; SNF2L2
Study NCT00549146 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04517630 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT04517630 — Predictive Biomarker (PRD): IGFBP7 mRNA
Genes: IGFBP7; MAC25; PSF
Study NCT04517630 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02192580 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Neutrophil gelatinase-associated lipocalin
Genes: LCN2; HNL; NGAL
Study NCT01999608 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT04456998 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT03580512 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT02459756 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03339336 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT02521285 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT02521285 — Predictive Biomarker (PRD): CDX2 mRNA
Genes: CDX2; CDX3
Study NCT01672567 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01672567 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT00873366 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT03747978 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01805960 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00343876 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02882542 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02265861 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02265861 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01334021 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01334021 — Predictive Biomarker (PRD): GCNT2 mRNA
Genes: GCNT2; GCNT5; II; NACGT1
Study NCT04827069 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04555486 — Predictive Biomarker (PRD): PHC3 mRNA
Genes: PHC3; EDR3; PH3
Study NCT02082535 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT02082535 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT01943851 — Predictive Biomarker (PRD): BCL6 mRNA
Genes: BCL6; BCL5; LAZ3; ZBTB27; ZNF51
Study NCT00072358 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00136409 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT01379573 — Predictive Biomarker (PRD): SSB mRNA
Genes: SSB
Study NCT02794142 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00569517 — Surrogate Endpoint (SUR): Blood pressure